Study of Management Practices of Bacteremia in a Referral Service in Dakar, Senegal (2018–2022)

Daouda Thioub *

Infectious and Tropical Diseases Department of Fann National University Hospital, Dakar, Senegal.

Zénab Malika Sokoba

Infectious and Tropical Diseases Department of Fann National University Hospital, Dakar, Senegal.

Khardiata Diallo Mbaye

Infectious and Tropical Diseases Department of Fann National University Hospital, Dakar, Senegal.

Ndèye Aissatou Lakhe

Infectious and Tropical Diseases Department of Fann National University Hospital, Dakar, Senegal.

Aboubakar Sidikh Badiane

Infectious and Tropical Diseases Department of Fann National University Hospital, Dakar, Senegal.

Ndèye Maguette Fall

Infectious and Tropical Diseases Department of Fann National University Hospital, Dakar, Senegal.

Daye Ka

Infectious and Tropical Diseases Department of Fann National University Hospital, Dakar, Senegal.

Viviane Marie Pierre Cisse

Infectious and Tropical Diseases Department of Fann National University Hospital, Dakar, Senegal.

Moussa Seydi

Infectious and Tropical Diseases Department of Fann National University Hospital, Dakar, Senegal.

*Author to whom correspondence should be addressed.


Abstract

Introduction: bacteremia remains a public health problem worldwide. Unfortunately, none of the studies carried out on this subject in our context has looked at how bacteremia is managed. We therefore undertook this study to assess the management practices of bacteremia at the infectious and Tropical diseases department.

Methods: this was a retrospective and descriptive study based on the analysis of records of patients hospitalized at Infectious and Tropical diseases department of Fann national university hospital in Dakar, Senegal. This study covered a five-year period, extending from January 1st 2018, to December 31 2022.

Results: During our study period, 213 patients were enrolled. The sex ratio was 1.13. The average age was 45.6 ± 17.5 years. Most patients (63.4%) had at least one comorbidity. Thirty-two percent (32%) had a history of recent hospitalization, and 25% had received recent antibiotic therapy. During the study period, 231 bacterial strains were isolated. Gram-positive cocci accounted for 68%, and Gram-negative bacilli for 32%. The main bacteria isolated were Staphylococcus aureus (30.3%). Empiric antibiotic therapy had been initiated in 81% of patients. Following antibiotic susceptibility testing, 61% of patients had their antibiotic therapy readjusted. In 61% of cases, the therapeutic protocol was deemed unsuitable, in line with the recommendations of Senegal's national antibiotic guide and international recommendations.

Conclusion: Bacteremias are common infections with significant morbidity and mortality that require a thorough understanding to improve management strategies and reduce AMR. In our context of low-income countries, following treatment guidelines is key to reducing AMR.

Keywords: Bacteremia, infectious diseases, bloodstream infections, HIV


How to Cite

Thioub, Daouda, Zénab Malika Sokoba, Khardiata Diallo Mbaye, Ndèye Aissatou Lakhe, Aboubakar Sidikh Badiane, Ndèye Maguette Fall, Daye Ka, Viviane Marie Pierre Cisse, and Moussa Seydi. 2024. “Study of Management Practices of Bacteremia in a Referral Service in Dakar, Senegal (2018–2022)”. Asian Journal of Research in Infectious Diseases 15 (7):29-35. https://doi.org/10.9734/ajrid/2024/v15i7360.

Downloads

Download data is not yet available.

References

Reddy EA, Shaw AV, Crump JA. Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10(6):417‑32.

Goto M, Al-Hasan MN. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clinical Microbiology and Infection. 2013;19(6):501‑9.

Miniño AM, Murphy SL, Xu J, Kochanek KD. Deaths: final data for 2008. Natl Vital Stat Rep. 2011;59(10):1‑126.

Ogulla G, Mwalimu S, Muturi M, Ouma C. Blood Cellular Changes Associated with Bacteremia and Malaria Co-morbidity among Children in Western, Kenya. Int. J. Trop. Dis. Health. [Internet]. 2020 Nov. 19 [cited 2024 Jun. 10];41(17):18-25.Available:https://journalijtdh.com/index.php/IJTDH/article/view/1029

Pérez-Rodríguez MT, Sousa A, Moreno-Flores A, Longueira R, Diéguez P, Suárez M, Lima O, Vasallo FJ, Álvarez-Fernández M, Crespo M. The benefits and safety of oral sequential antibiotic therapy in non-complicated and complicated Staphylococcus aureus bacteremia. International Journal of Infectious Diseases. 2021;102:554-60 .

Bodro M, Gudiol C, Garcia-Vidal C, Tubau F, Boix L, Domingo-Domenech E, Calvo M, Carratalà J. Epidemiology, antibiotic therapy and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in cancer patients. Supportive Care in Cancer. 2014;22:603-10.

Zaragoza R, Artero A, Camarena JJ, Sancho S, González R, Nogueira JM. The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit. Clin Microbiol Infect. 2003;9(5):412‑8.

Marschall J, Agniel D, Fraser VJ, Doherty J, Warren DK. Gram-negative bacteraemia in non-ICU patients: factors associated with inadequate antibiotic therapy and impact on outcomes. J Antimicrob Chemother. 2008;61(6):1376‑83.

Carpentier J-P, Petrognani R, Morillon M. Bactériémies. EMC - Maladies infectieuses. 2004;1:1‑7.

Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. févr 1999;115(2):462‑74.

ePilly Trop : Maladies infectieuses tropicales. 3e édition. 2022.

Gauzit R, Castan B, Bonnet E, Bru JP, Cohen R, Diamantis S, et al. Anti-infectious treatment duration: The SPILF and GPIP French guidelines and recommendations. Infectious Diseases Now. 2021;51(2):114‑39.

MSAS. Guide national pour un bon usage des antibiotiques. Ministère de la Santé et de l’Action Sociale; 2021.

Lakhe A, Sylla K, Mbaye K, Ndiaye R, Cisse V, KA D, et al. Bacteremia: Profile and Antibiotic Resistance at the Infectious and Tropical Diseases Clinic in Fann Hospital, Dakar, Senegal. Journal of Infectious Diseases & Therapy. 2018;06.

Hill PC, Onyeama CO, Ikumapayi UN, Secka O, Ameyaw S, Simmonds N, et al. Bacteraemia in patients admitted to an urban hospital in West Africa. BMC Infectious Diseases. 2007;7(1):2.

Akoua-Koffi C, Tia H, Plo JK, Monemo P, Cissé A, Yao C, et al. Epidemiology of community-onset bloodstream infections in Bouaké, central Côte d’Ivoire. New Microbes and New Infections. 2015;7:100‑4.

Anderson DJ, Moehring RW, Sloane R, Schmader KE, Weber DJ, Jr VGF, et al. Bloodstream Infections in Community Hospitals in the 21st Century: A Multicenter Cohort Study. PLOS ONE. 2014; 9(3):e91713.

Ngoyi ENO, Otiobanda GF, Mahoungou-Guimbi CK, Obengui, Moyen R, Moyen GM. Apport de l’hémoculture dans le diagnostic des bactériémies au Centre (...) - Société de l’Anesthésie Réanimation d’Afrique Francophone. RAMUR. 2014;19(1):15‑8.

Huson MAM, Stolp SM, van der Poll T, Grobusch MP. Community -acquired bacterial bloodstream infections in HIV-infected patients: a systematic review. Clin Infect Dis. 2014;58(1): 79‑92.

Seydi M, Sow AI, Soumaré M, Diallo HM, Hatim B, Tine R, et al. Status of Staphylococcus aureus bacteremia at the Fann University Hospital in Dakar. Médecine et Maladies Infectieuses. 2004;34(5):210‑5.

Alonso-Menchén D, Muñoz P, Sánchez-Carrillo C, Pérez-Latorre L, Bouza E. Unresolved issues in the epidemiology and diagnosis of bacteremia: an opinion paper. Rev Esp Quimioter. 2022;35(6):519-537.

Seydi M, Sow PS, Soumaré M, Ndour CT, Dia NM, Diop BM, et al. Bacteremia during AIDS in Dakar, Senegal. Med et Mal Infect. 2003;33(6):323‑6.

Martinez RM, Wolk DM. Bloodstream Infections. Microbiol Spectr. 2016;4(4).

Mbaye K, Lakhe A, Sylla K, Ndiaye A, Cisse V, Ka D, et al. Enterobacterial Infections Diagnosed at the Clinic of Infectious Diseases of Fann Hospital (2013-2014) Dakar, Senegal. Advances in Infectious Diseases. 2018;08:217‑28.

Choo EJ, Chambers HF. Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia. Infect Chemother. 2016;48(4):267‑73.

Daneman N, Shore K, Pinto R, Fowler R. Antibiotic treatment duration for bloodstream infections in critically ill patients: a national survey of Canadian infectious diseases and critical care specialists. International Journal of Antimicrobial Agents. 2011;38(6):480‑5.

Nielsen ND, Dean JT III, Shald EA, Conway Morris A, Povoa P, Schouten J, Parchim N. When to Stop Antibiotics in the Critically Ill? Antibiotics. 2024; 13(3):272.

Timsit J-F, Soubirou J-F, Voiriot G, Chemam S, Neuville M, Mourvillier B, et al. Treatment of bloodstream infections in ICUs. BMC Infect Dis. 2014; 14:489.